ScreenerHero

ACOU AcouSort AB (publ)

STO · SE · Healthcare · Biotechnology · acousort.com
3.000SEK-8.54%Mkt Cap: 6.07M $P/E: —

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample prepara…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap6.07M USD
Enterprise Value5.73M USD
Revenue (TTM)890.90K USD
Gross Profit644.89K USD
Net Income (TTM)-1.16M USD
Revenue/Share0.44 SEK
Last Price3.000 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.10
PEG—
EV/EBITDA-5.15
EV/Revenue6.44
P/S7.45
P/B7.08
EPS (TTM)-0.52
EPS (Forward)-0.80
52W Range
2.03031% of range5.160
52W High5.160 SEK
52W Low2.030 SEK
Profitability
Gross Margin98.38%
Oper. Margin-168.67%
EBITDA Margin-124.93%
Profit Margin-177.34%
ROE-74.55%
ROA-67.92%
Growth
Revenue Growth-25.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.61M USD
CapEx (TTM)46.68K USD
FCF Margin-34.89%
FCF Yield-5.12%
Net Debt-906.97K USD
Net Debt/EBITDA0.81
Balance Sheet
Debt/Equity—
Current Ratio1.41
Quick Ratio1.07
Book Value/Sh0.46 SEK
Cash/Share0.45 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)9.000 SEK
Upside (mean)+200.0%
Target Range9.000 SEK – 9.000 SEK
# Analysts1
Ownership
Shares Out.21.16M
Float15.77M
Insiders29.32%
Institutions16.86%
Technical
SMA 503.079 (-2.6%)
SMA 2003.294 (-8.9%)
Beta0.13
S&P 52W Chg16.45%
Avg Vol (30d)36.22K
Avg Vol (10d)64.61K
Technical Indicators
RSI (14)50.3
MACD0.0107
MACD Signal-0.0538
MACD Hist.+0.0645
BB Upper3.475 SEK
BB Middle2.887 SEK
BB Lower2.299 SEK
BB Width40.72%
ATR (14)0.3604 SEK
Vol Ratio (20d)1.62x